Pfizer's Hospira Unveils LifeCare PCA 7.0 Infusion System

Pfizer Inc PFE's Hospira unveiled the LifeCare PCA 7.0 Infusion System. According to the company, as the first patient-controlled analgesia (PCA) infusion pump to provide electronic medical record (EMR) integration, LifeCare PCA 7.0 is a next-generation infusion system.

Hospira said it allows device auto-programming and streamlines documentation of infusion data to help improve the safety, as well as, efficiency of pain management medication administration. The company added it's the first and only PCA pump with integrated bar code identification of prefilled and pharmacy-filled drug vials, substantially eliminating the potential for drug and concentration errors at the bedside.

The company said medication errors affect 1.5 million people while costing $21 billion annually. Moreover, the EMR integration, as well as, bar-code technology help give health care providers confidence that the right drug is being administered to the patient at the right dose and in the right concentration.

Hospira's President for Infusion System, Julie Sawyer Montgomery, said, "Hospira is proud to deliver the first PCA smart pump that can integrate directly with the EMR. With the new integration capabilities and enhanced cybersecurity features, the clearance of LifeCare PCA 7.0 ushers in a new phase in IV-EMR connectivity and pain management therapy. It also underscores Hospira's leadership in delivering technology to meet the evolving needs of health care providers in medication error prevention and clinician efficiency."

The company indicated its new LifeCare PCA 7.0 device is available for customers to order. Hospira revolutionized pain management therapy by launching the first hospital PCA device in the industry over 30 years back.

Posted In: BiotechNewsGeneral
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...